Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
Maria V. Deligiorgi, Sofia Sagredou, Lampros Vakkas, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5277-5277
Open Access | Times Cited: 16

Showing 16 citing articles:

Thyroid disorders induced by immune checkpoint inhibitors
Dimitra Karaviti, Eleni-Rafaela Kani, Eleftheria Karaviti, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 67-79
Open Access | Times Cited: 11
Thyroid-related adverse events induced by immune checkpoint inhibitors
Alexandra Chera, Andreea Lucia Stancu, Octavian Bucur
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Association between platelet-to-lymphocyte ratio and immune checkpoint inhibitor-induced thyroid dysfunction
Wang Ai, Huijie Huang, Yangli Chen, et al.
Endocrine (2025)
Closed Access
Association of MTNR1B Gene Polymorphisms with Body Mass Index in Hashimoto’s Thyroiditis
Ivana Škrlec, Zrinka Biloglav, Davor Lešić, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3667-3667
Open Access
Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5786-5786
Open Access | Times Cited: 10
Clinical use of thyroglobulin: not only thyroid cancer
Agata Berlińska, Renata Świątkowska‐Stodulska
Endocrine (2024) Vol. 84, Iss. 3, pp. 786-799
Open Access | Times Cited: 3
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 12
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Víctor Albarrán-Artahona, Juan Carlos Laguna, Teresa Gorría, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2091-2091
Open Access | Times Cited: 12
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records
Mathilde Beaufils, Vincent Amodru, Manuel Tejeda, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006786-e006786
Open Access | Times Cited: 4
Primary Thyroid Dysfunction Is Prevalent in Hidradenitis Suppurativa and Marked by a Signature of Hypothyroid Graves’ Disease: A Case–Control Study
Nessr Abu Rached, Johannes W. Dietrich, Lennart Ocker, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7490-7490
Open Access | Times Cited: 4
Pediatric thyroid side effects of immune checkpoint inhibitors
Cesare Morgante, Alessandra Fierabracci, Armando Grossi
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 9, pp. 765-768
Closed Access | Times Cited: 1
Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency
Fabrizio Nelli, Enzo Maria Ruggeri, Marta Schirripa, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 7647-7662
Open Access | Times Cited: 1
The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum
Maria V. Deligiorgi, Dimitrios T. Trafalis
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3417-3417
Open Access | Times Cited: 7
Thyroid-related Adverse Events Caused by Immune Checkpoint Inhibitors Associated with Therapeutic Outcomes in Cancer Patients: a systematic review and meta-analysis
Yuhao Wei, Yun Hong, Xueyan Zhou, et al.
Research Square (Research Square) (2023)
Open Access
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer
Maria V. Deligiorgi, Dimitrios T. Trafalis
Personalized Medicine (2022) Vol. 20, Iss. 1, pp. 87-105
Closed Access
Endocrine Toxicities Related to Immunotherapy
Mark Quinn, Paul Carroll, Mamta Joshi
Springer eBooks (2022), pp. 1-40
Closed Access
Page 1

Scroll to top